33
https://pubmed.ncbi.nlm.nih.gov/38095131
Silencing Troponin T1 inhibits paclitaxel resistance and breast cancer progression by suppressing the RAS/RAF1 pathway, suggesting a potential biomarker and therapeutic target for drug resistance in breast cancer.